There's a lot of fiction surrounding stem-cell facts. To separate one from the other, WebMD has consulted experts including Mahendra Rao, MD, PhD, director of the Center for Regenerative Medicine at the National Institutes of Health; Todd McDevitt, PhD, director of the Stem Cell Engineering Center at Georgia Tech; Mary Laughlin, MD, past president of the International Society for Cellular Therapy; and Joshua Hare, MD, director of the Interdisciplinary Stem Cell Institute at the University of Miami.
Here are the questions they answered:
A: The term "stem cells" includes many different kinds of cells.
What they have in common is that they have the ability to make other types of cells. No other cell in the body can do that.
Some stem cells can renew themselves and become virtually any cell in the body. Those are called pluripotent stem cells. They include embryonic stem cells.
Other stem cells don't have as much potential for self-renewal and can't make as many types of cells.
The most basic kind of stem cells are the cells that make up an embryo soon after an egg is fertilized. These stem cells divide over and over, eventually making almost all the different cells in the body.
Adult stem cells, in contrast, are "fully differentiated." That means they are what they are and do what they do. They can't choose another career.
In many organs, however, adult stem cells linger throughout life. They are part of the body's internal repair system. Researchers are still working to discover what adult stem cells from various parts of the body can and can't do. Normally, these relatively rare cells act only on the organ or tissue type in which they are found.
Recently, researchers have learned to reprogram adult cells to become pluripotent cells. These cells, called induced pluripotent cells or iPSCs, have many of the same properties as embryonic stem cells. It's not yet clear whether these cells might carry subtle DNA damage that limits their usefulness.
A: Early in development, a fertilized egg becomes an embryo. The embryo is made up of stem cells that divide over and over again, until these stem cells develop into the cells and tissues that become a fetus.
During in-vitro fertilization, eggs taken from a woman's body are fertilized with sperm cells. If not implanted in a woman's womb, these embryos are discarded.
Researchers have learned to take embryonic stem cells from unused in-vitro fertilizations and, in laboratory culture, to get them to make more embryonic stem cells. Embryonic stem cells are not taken from fertilized eggs or embryos that have been in a woman's womb.
While embryonic stem cells can become any kind of cell in the body, it's unlikely they would be used directly as treatments. Because they have the ability to divide over and over again, they can become rapidly growing tumors. And because they are in such an early stage of development, they take a long time to become functional adult cells.
However, researchers are learning to coax embryonic stem cells to become more mature stem cells. One clinical trial, for example, matures embryonic stem cells into nerve stem cells. These nerve stem cells are being explored as a treatment for Lou Gehrig's disease.
A: Adult stem cells have some advantages. When they come from your own body, your immune system will probably not try to reject them. And adult stem cells aren't controversial.
But there are several main disadvantages to using adult stem cells:
A: A relatively small number of stem cells taken from the body can be grown in the laboratory until they have created millions and millions of new stem cells. This makes it possible for researchers to explore cell-based therapies.
Cell-based therapies, collectively known as regenerative medicine, hold the promise of repairing or even replacing damaged or diseased organs.
Depending on which tissues they come from, stem cells have very different properties. Those from umbilical cord blood are quite different from those from fat, for example.
A: Yes. Stem cells from bone marrow have long been used to treat certain types of leukemia.
The bone marrow is a rich source of blood stem cells. These cells replace the white blood cells crucial to the immune system.
When used for leukemia, the goal is to to wipe out all of a person's white blood cells with radiation and/or chemotherapy -- and then to replace them with a bone marrow transplant from a matched donor. Stem cells from the donor marrow replace the diseased blood cells with healthy blood cells.
A stem cell product designed to avoid the need for a matched donor recently received limited approval in Canada. The product, Prochymal, appears to rescue bone marrow transplant patients who are rejecting their transplant.
In the U.S., the FDA has approved a product called Hemacord, which contains blood stem cells derived from cord blood. The product is approved for patients with diseases that affect their ability to make new blood cells, such as certain blood cancers and immune disorders.
A: That remains to be seen. Potential dangers include:
There is also risk in some of the procedures used to get stem cells out of the body (such as from liposuction or spinal tap) or to deliver stem cells to the body (such as implanting them in the heart, brain, spinal cord, or other organs). That's not so much about the stem cells, but because of the procedures themselves.
Researchers are studying all of that. Without carefully controlled clinical trials, there's no way to know what might happen in the long term, or even in the short term. That's why the FDA discourages the use of stem cells except in clinical trials or approved therapies.
If you are thinking about pursuing stem cell therapy, talk to your doctor first. In the U.S. and abroad, many clinics offer unproven stem cell treatments that have never been tested for safety or effectiveness.
Mahendra Rao, MD, PhD, director, Center for Regenerative Medicine, National Institutes of Health, Bethesda, Md.
Todd McDevitt, PhD, director, Stem Cell Engineering Center, Georgia Institute of Technology, Atlanta.
Mary Laughlin, MD, past president of the International Society for Cellular Therapy.
Joshua Hare, MD, director, Interdisciplinary Stem Cell Institute, University of Miami.
National Institutes of Health web site.
FDA web site.
- Newborn in Japan receives first treatment with liver STEM cells - ZME Science - May 23rd, 2020
- Adult Stem Cells Market with Coronavirus (Covid-19) Impact Analysis | Industry Strong Development By Major Eminent Players, New Innovations, Key... - May 16th, 2020
- Stem Cell and Regenerative Therapy Market Covid-19 Impact Analysis, Size, Share & Trends Analysis Report by Component, By Enterprise Size, By End... - May 16th, 2020
- The RNA binding protein CPEB2 regulates hormone sensing in mammary gland development and luminal breast cancer - Science Advances - May 16th, 2020
- Stem Cells Market Market Developments and Analysis (impact of Covid-19) 2020-2026 - Herald Writeup - May 15th, 2020
- Takeda Pharmaceutical : China announces ADCETRIS (brentuximab vedotin) is approved for the treatment of adult patients with CD30-positive Lymphomas -... - May 15th, 2020
- New Data for Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001 for Severe Hemoglobinopathies Accepted for Oral Presentation at the 25th European... - May 14th, 2020
- Dlp-mediated Hh and Wnt signaling interdependence is critical in the niche for germline stem cell progeny differentiation - Science Advances - May 14th, 2020
- Little Skates Could Hold the Key to Cartilage Therapy in Humans - Technology Networks - May 14th, 2020
- Strides in Medical Tourism Market Key Driver of Low-cost Patient Care in Globalized Healthcare Systems, Notes TMR - PR Newswire UK - May 14th, 2020
- Australia's Mesoblast raises $90M to scale up stem cell therapy manufacturing to treat COVID-19 ARDS - BioWorld Online - May 14th, 2020
- CTX001 for Treatment of Sickle Cell Disease and Other Blood Disorders - Sickle Cell Anemia News - May 14th, 2020
- Stem cells therapy A prospective treatment against coronavirus? - Daily Excelsior - May 14th, 2020
- Protocol Management, Off-the-Shelf Therapies Help Bring CAR T Into More Settings - Targeted Oncology - May 13th, 2020
- BrainStorm Leases a New Cleanroom Facility at The Tel Aviv Sourasky Medical Center to Manufacture NurOwn for The European Union - Yahoo Finance - May 13th, 2020
- CRISPR Therapeutics and Vertex Pharmaceuticals Announce FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX001 for the... - May 13th, 2020
- Study: Want to lose weight? Get rid of that pesky nose - The Big Smoke Australia - May 13th, 2020
- Region 3: Immune and Cellular Tx, Part II - MedPage Today - May 9th, 2020
- Rituximab Offers No Extra Benefit to Induction Chemo in ALL - Medscape - May 9th, 2020
- ROCKET PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - marketscreener.com - May 9th, 2020
- BrainStorm Leases a New Cleanroom Facility at The Tel Aviv Sourasky Medical Center to Manufacture NurOwn for The European Union - BioSpace - May 7th, 2020
- Stem Cells Market 2020 Size, Global Trends, Comprehensive Research Study, Development Status, Opportunities, Future Plans, Competitive Landscape and... - May 7th, 2020
- Chinas scientists accused of playing God by creating monstrous cloned apes and primates with human organs - The Sun - May 7th, 2020
- Roeland Nusse receives Canada's Gairdner International Award | The Dish - Stanford University News - May 7th, 2020
- Broad Foundation brings together stem cell scientists, engineers and physicians at University of Southern - Mirage News - May 7th, 2020
- Schizophrenia drug points to improved brain cancer radiation therapy - New Atlas - May 7th, 2020
- Scientists finally explained one of the strangest coronavirus symptoms - BGR - May 5th, 2020
- What Do New Neurons in the Brains of Adults Actually Do? - The Scientist - May 5th, 2020
- Therapy Harnesses Immune System to Slow Progression of DIPG Brain Tumors - University of Michigan Health System News - May 5th, 2020
- Acute Myeloid Leukemia Therapeutics Market Latest Innovations, Drivers and Industry Key Events During Forecast 2017 2025 - Jewish Life News - May 5th, 2020
- Stemline Slated for Acquisition by Menarini in Deal Worth Up to $677M - Xconomy - May 4th, 2020
- Teva and Celltrion Healthcare Announce the Launch of TRUXIMA (rituximab-abbs) Injection for Rheumatoid Arthritis, the Only Biosimilar to Rituxan... - May 4th, 2020
- Genmab Announces U.S. FDA Approval of Subcutaneous Formulation of Daratumumab, DARZALEX FASPRO (daratumumab and hyaluronidase-fihj), for the Treatment... - May 4th, 2020
- Stem cell therapy shows 83% survival of Coronavirus patients on ventilators - International Business Times, Singapore Edition - April 26th, 2020
- There's no treatment for COVID-19, but Virginia researchers are ramping up clinical trials to try to find one - Richmond.com - April 26th, 2020
- Newest American Academy of Arts and Sciences members | Stanford News - Stanford University News - April 26th, 2020
- 'I Will Not Kill Children to Live' - Church Militant - April 24th, 2020
- Morning Update: Canadas data gaps are hurting our ability to fight the pandemic - The Globe and Mail - April 24th, 2020
- Adult Stem Cell - an overview | ScienceDirect Topics - April 12th, 2020
- Coronavirus updates: Masks required for take out; N.J. hospitalizations to peak within 3 weeks; Stimulus paym - NJ.com - April 12th, 2020
- 4 ways to promote neurogenesis in your brain - Big Think - April 9th, 2020
- Funding roundup: At-home medical exams and a Parkinson's treatment - MedCity News - April 9th, 2020
- Moderna: A $12 Billion Brand Built On Hope And mRNA - Seeking Alpha - April 9th, 2020
- BrainStorm Awarded $1.5 Million Non-Dilutive Grant for 2020 by the Israel Innovation Authority - Yahoo Finance - April 3rd, 2020
- Post-Remission Therapy For AML: Allogeneic Stem-Cell Transplant - SurvivorNet - April 3rd, 2020
- Intermittent fasting might boost the creation of new neurons in a key brain structure - PsyPost - April 3rd, 2020
- 4 relationship problems that can be linked back to early childhood - Big Think - March 28th, 2020
- Scientists Have 'Reset' The Cellular Age Of Cells Taken From A 114-Year-Old Woman - IFLScience - March 26th, 2020
- The Answer to the Coronavirus Is More Abortion? - Townhall - March 24th, 2020
- Mesoblast limited (NASDAQ:MESO) Given Consensus Rating of Buy by Brokerages - Redmond Register - March 21st, 2020
- Stem Cell And Regenerative Therapy Market 2019-2024 Chain Analysis, Upstream Raw Materials Sourcing and Downstream Buyers - Feed Road - March 15th, 2020
- Scientists Create Human 'Body-On-A-Chip' Featuring Tiny Replica Organs In The Lab - IFLScience - March 14th, 2020
- Adult Stem Cells - March 12th, 2020
- Australia's Mesoblast plans to evaluate its stem cell therapy in patients infected with COVID-19 - BioWorld Online - March 12th, 2020
- How to build a body from scratch, Altered Carbon-style - SYFY WIRE - March 12th, 2020
- Astronauts growing new organs on International Space Station - The Independent - March 12th, 2020
- The Inside Scoop on Northwest Biotherapeutics, Inc (OTCMKTS: NWBO) - MicroCap Daily - March 9th, 2020
- Adult Stem Cells: Market 2020 New Innovative Solutions to Boost Global Growth with New Technology, Key Business Strategies, Trend and Forecasts 2024 -... - March 6th, 2020
- Review Finds The Effects Of Obesity On The Body Mirror Those Of Aging - IFLScience - February 29th, 2020
- Stem Cells Market is expected to reach US$270.5 billion by 2025, TMR - BioSpace - February 24th, 2020
- Olive Oil Consumption Could Lead to a 'Younger Brain' in the Elderly, Researchers Say - Olive Oil Times - February 24th, 2020
- New sickle cell disease treatments are helping people live longer and giving them a higher quality of life - PhillyVoice.com - February 24th, 2020
- Proteostasis Therapeutics and CF Europe Announce Completion of Patient Enrollment for CHOICES, the First-Ever Personalized Medicine-Based Study in... - February 24th, 2020
- Transplant for Szary Syndrome is Patient's First Step in Returning to the Dance Floor - Dana-Farber Cancer Institute - February 22nd, 2020
- Eternal youth and good health from stem cells soon within reach? - Innovation Origins - February 22nd, 2020
- How do body parts grow to their right sizes? - The Week Magazine - February 22nd, 2020
- 8-year-old bone marrow recipient and donor celebrate in emotional reunion - WFAA.com - February 16th, 2020
- Singapore researchers discover Human Stem Cells and Cancer Origins in Stomach - BSA bureau - February 14th, 2020
- Stem Cell And Regenerative Therapy Market Sales Volume, Status, Growth, Opportunities and World - Instant Tech News - February 14th, 2020
- Astrocytes could be harnessed to protect motor neurons in MND - Drug Target Review - February 11th, 2020
- BrainStorm Cell Therapeutics and FDA Agree to Potential NurOwn Regulatory Pathway for Approval in ALS - Yahoo Finance - February 11th, 2020
- Mexico City Medical Congress to Showcase the Global Stem Cells Group's Latest Innovations - PRUnderground - February 11th, 2020
- Bone Therapeutics to present preclinical data on the osteogenic properties of ALLOB in bone repair at the Annual Meeting of the Orthopaedic Research... - February 11th, 2020
- Stopping Smoking Allows Healthy Lung Cells to Proliferate - Medscape - February 6th, 2020
- Biological robots, that is a thing now - 702 - February 6th, 2020
- How the next trip to the moon will get us ready for Mars - Deseret News - February 6th, 2020
- Knocking Down Levels Of These Proteins Could Reverse Type 2 Diabetes - International Business Times - February 6th, 2020
- Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal C | CCID - Dove Medical Press - February 2nd, 2020
- People who develop Parkinson's before 50 may have been born with damaged brain cells, says study - MEAWW - February 2nd, 2020
- Single-cell analysis reveals different age-related somatic mutation profiles between stem and differentiated cells in human liver - Science Advances - January 31st, 2020